The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Agonist‐selective mechanisms of GPCR desensitization
Open accessAbstract
The widely accepted model of G protein‐coupled receptor (GPCR) regulation describes a system where the agonist‐activated receptors couple to G proteins to induce a cellular response, and are subsequently phosphorylated by a family of kinases called the G protein‐coupled receptor kinases (GRKs). The GRK‐phosphorylated receptor then acts as a substrate for the binding of a family of proteins called arrestins, which uncouple the receptor and G protein so desensitizing the agonist‐induced response. Other kinases, principally the second messenger‐dependent protein kinases, are also known to play a role in the desensitization of many GPCR responses. It is now clear that there are subtle and complex interactions between GRKs and second messenger‐dependent protein kinases in the regulation of GPCR function. Functional selectivity describes the ability of agonists to stabilize different active conformations of the same GPCR. With regard to desensitization, distinct agonist‐activated conformations of a GPCR could undergo different molecular mechanisms of desensitization. An example of this is the μ opioid receptor (MOPr), where the agonists morphine and [D‐Ala 2,N‐MePhe 4,Gly‐ol 5]enkephalin (DAMGO) induce desensitization of the MOPr by different mechanisms, largely protein kinase C (PKC)‐ or GRK‐dependent, respectively. This can be best explained by supposing that these two agonists stabilize distinct conformations of the MOPr, which are nevertheless able to couple to the relevant G‐proteins and produce similar responses, yet are sufficiently different to trigger different regulatory processes. There is evidence that other GPCRs also undergo agonist‐selective desensitization, but the full therapeutic consequences of this phenomenon await further detailed study. British Journal of Pharmacology(2008)153, S379–S388; doi:10.1038/sj.bjp.0707604; published online 3 December 2007
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferguson, S. S. G. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01478-9 · Cited by 1,826
β-Arrestins and Cell Signaling
DeWire, S. M., Ahn, S., Lefkowitz, R. J., & Shenoy, S. K. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.022405.154749 · Cited by 1,397
G PROTEIN–COUPLED RECEPTOR KINASES
Pitcher, J. A., Freedman, N. J., & Lefkowitz, R. J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.653 · Cited by 1,361
Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A
Daaka, Y., Luttrell, L. M., & Lefkowitz, R. J. (1997) · Nature · doi:10.1038/36362 · Cited by 1,270
Turning off the signal: desensitization of β‐adrenergic receptor function
Hausdorff, W. P., Caron, M. G., & Lefkowitz, R. J. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.11.2165947 · Cited by 1,249
β-Arrestin: a Protein that Regulates β-adrenergic Receptor Function
Lohse, M. J., Benovic, J. L., Codina, J., Caron, M. G., & Lefkowitz, R. J. (1990) · Science · doi:10.1126/science.2163110 · Cited by 1,220
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,116
THE ROLE OF RECEPTOR KINASES AND ARRESTINS IN G PROTEIN–COUPLED RECEPTOR REGULATION
Krupnick, J. G., & Benovic, J. L. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.289 · Cited by 1,103
Cellular and Synaptic Adaptations Mediating Opioid Dependence
Williams, J. T., Christie, M. J., & Manzoni, O. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.299 · Cited by 848
Benovic, J. L., Strasser, R. H., Caron, M. G., & Lefkowitz, R. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.9.2797 · Cited by 662
G protein coupled receptor structure and activation
Kobilka, B. K. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.10.021 · Cited by 623
Morphine Activates Opioid Receptors without Causing Their Rapid Internalization
Keith, D. E., Murray, S. R., Zaki, P. A., Chu, P. C., Lissin, D. V., Kang, L., Evans, C. J., & von Zastrow, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19021 · Cited by 552
Zhang, J., Ferguson, S. S. G., Barak, L. S., Bodduluri, S. R., Laporte, S. A., Law, P.-Y., & Caron, M. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.7157 · Cited by 505
Physiological Roles of G Protein–Coupled Receptor Kinases and Arrestins
Premont, R. T., & Gainetdinov, R. R. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.022405.154731 · Cited by 494
Hausdorff, W. P., Bouvier, M., O'Dowd, B. F., Irons, G. P., Caron, M. G., & Lefkowitz, R. J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63907-9 · Cited by 414
Ribas, C., Penela, P., Murga, C., Salcedo, A., García-Hoz, C., Jurado-Pueyo, M., Aymerich, I., & Mayor, F. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.09.019 · Cited by 408
Lohse, M. J., Benovic, J. L., Caron, M. G., & Lefkowitz, R. J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39754-6 · Cited by 401
Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2
Lorenz, K., Lohse, M. J., & Quitterer, U. (2003) · Nature · doi:10.1038/nature02158 · Cited by 384
Kohout, T. A., Nicholas, S. L., Perry, S. J., Reinhart, G., Junger, S., & Struthers, R. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402125200 · Cited by 333
Modulation of Postendocytic Sorting of G Protein-Coupled Receptors
Whistler, J. L., Enquist, J., Marley, A., Fong, J., Gladher, F., Tsuruda, P., Murray, S. R., & von Zastrow, M. (2002) · Science · doi:10.1126/science.1073308 · Cited by 325
Benovic, J. L., Pike, L. J., Cerione, R. A., Staniszewski, C., Yoshimasa, T., Codina, J., Caron, M. G., & Lefkowitz, R. J. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)88892-5 · Cited by 320
Multiple Signaling States of G-Protein-Coupled Receptors
Perez, D. M., & Karnik, S. S. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.2 · Cited by 237
Groer, C. E., Tidgewell, K., Moyer, R. A., Harding, W. W., Rothman, R. B., Prisinzano, T. E., & Bohn, L. M. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.028258 · Cited by 224
Type-specific Sorting of G Protein-coupled Receptors after Endocytosis
Tsao, P. I., & von Zastrow, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11130 · Cited by 219
Sequestration of the δ Opioid Receptor
Trapaidze, N., Keith, D. E., Cvejic, S., Evans, C. J., & Devi, L. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29279 · Cited by 200
Arriza, J., Dawson, T., Simerly, R., Martin, L., Caron, M., Snyder, S., & Lefkowitz, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-10-04045.1992 · Cited by 195
Pitcher, J., Lohse, M. J., Codina, J., Caron, M. G., & Lefkowitz, R. J. (1992) · Biochemistry · doi:10.1021/bi00127a021 · Cited by 194
Schulz, S., Mayer, D., Pfeiffer, M., Stumm, R., Koch, T., & Höllt, V. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600334 · Cited by 180
Krasel, C., Bünemann, M., Lorenz, K., & Lohse, M. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413078200 · Cited by 178
P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms
Hardy, A. R., Conley, P. B., Luo, J., Benovic, J. L., Poole, A. W., & Mundell, S. J. (2005) · Blood · doi:10.1182/blood-2004-07-2893 · Cited by 176
Bohn, L. M., Dykstra, L. A., Lefkowitz, R. J., Caron, M. G., & Barak, L. S. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.1.106 · Cited by 171
Cong, M., Perry, S. J., Lin, F.-T., Fraser, I. D., Hu, L. A., Chen, W., Pitcher, J. A., Scott, J. D., & Lefkowitz, R. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009130200 · Cited by 170
Receptor Endocytosis Counteracts the Development of Opioid Tolerance
Koch, T., Widera, A., Bartzsch, K., Schulz, S., Brandenburg, L.-O., Wundrack, N., Beyer, A., Grecksch, G., & Höllt, V. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.004994 · Cited by 167
Borgland, S. L., Connor, M., Osborne, P. B., Furness, J. B., & Christie, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300525200 · Cited by 165
Phosphorylation and Activation of β-Adrenergic Receptor Kinase by Protein Kinase C
Chuang, T. T., LeVine, H., & De Blasi, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.31.18660 · Cited by 162
Namkung, Y., & Sibley, D. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408319200 · Cited by 157
Tran, T. M., Friedman, J., Qunaibi, E. A., Baameur, F., Moore, R. H., & Clark, R. B. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.1.196 · Cited by 153
Johnson, E. A., Oldfield, S., Braksator, E., Cuello, A. M. G., Couch, D., Hall, K. J., Mundell, S. J., Bailey, C. P., Kelly, E., & Henderson, G. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.022376 · Cited by 153
Self-citationStructure and Conformational Changes in the C-terminal Domain of the β2-Adrenoceptor
Granier, S., Kim, S., Shafer, A. M., Ratnala, V. R. P., Fung, J. J., Zare, R. N., & Kobilka, B. K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611904200 · Cited by 150
Morphine Promotes Rapid, Arrestin-Dependent Endocytosis of μ-Opioid Receptors in Striatal Neurons
Haberstock-Debic, H., Kim, K., Yu, Y., & von Zastrow, M. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.5045-04.2005 · Cited by 148
RNA‐editing of the 5‐HT2C receptor alters agonist‐receptor‐effector coupling specificity
Berg, K. A., Cropper, J. D., Niswender, C. M., Sanders‐Bush, E., Emeson, R. B., & Clarke, W. P. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704255 · Cited by 147
Clark, R. B., Kunkel, M. W., Friedman, J. E., Goka, T. J., & Johnson, J. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.5.1442 · Cited by 146
Partial agonists and G protein-coupled receptor desensitization
Clark, R. B., Knoll, B. J., & Barber, R. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01351-6 · Cited by 145
Introduction to Special Section on β-Arrestins
Lefkowitz, R. J. (2007) · Annual Review of Physiology · doi:10.1146/annurev.ph.69.013107.100021 · Cited by 145
μ‐Opioid receptor desensitization: Is morphine different?
Connor, M. A., Osborne, P. B., & Christie, M. J. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705938 · Cited by 141
Phosphorylation-independent attenuation of GPCR signalling
Ferguson, S. S. G. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.02.008 · Cited by 120
Zeitz, K. P., Malmberg, A. B., Gilbert, H., & Basbaum, A. I. (2001) · Pain · doi:10.1016/s0304-3959(01)00353-0 · Cited by 118
How important is protein kinase C in μ-opioid receptor desensitization and morphine tolerance?
Bailey, C. P., Smith, F. L., Kelly, E., Dewey, W. L., & Henderson, G. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.09.006 · Cited by 109
Self-citationNon-visual GRKs: are we seeing the whole picture?
Willets, J. M., Challiss, R. A. J., & Nahorski, S. R. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.10.003 · Cited by 107
Phosphorylation and regulation of a G protein–coupled receptor by protein kinase CK2
Torrecilla, I., Spragg, E. J., Poulin, B., McWilliams, P., Mistry, S. C., Blaukat, A., & Tobin, A. B. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200610018 · Cited by 103
Cho, E.-Y., Cho, D.-I., Park, J. H., Kurose, H., Caron, M. G., & Kim, K.-M. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0202 · Cited by 100
G‐protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal
Terman, G. W., Jin, W., Cheong, Y. P., Lowe, J., Caron, M. G., Lefkowitz, R. J., & Chavkin, C. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705595 · Cited by 99
Luk, T., Jin, W., Zvonok, A. M., Lu, D., Lin, X., Chavkin, C., Makriyannis, A., & Mackie, K. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705792 · Cited by 99
Localization of the Sites Mediating Desensitization of the β2-Adrenergic Receptor by the GRK Pathway
Seibold, A. M., Williams, B., Huang, Z.-F., Friedman, J., Moore, R. H., Knoll, B. J., & Clark, R. B. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.5.1162 · Cited by 98
Bailey, C. P., Kelly, E., & Henderson, G. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.004747 · Cited by 96
Self-citationTrester-Zedlitz, M., Burlingame, A. L., Kobilka, B. K., & von Zastrow, M. (2005) · Biochemistry · doi:10.1021/bi0475469 · Cited by 95
Yuan, N., Friedman, J. E., Whaley, B. S., & Clark, R. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31615-0 · Cited by 88
Phosphorylation-independent β-Arrestin Translocation and Internalization of Leukotriene B4 Receptors
Jala, V. R., Shao, W.-H., & Haribabu, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409821200 · Cited by 87
Bailey, C. P., Couch, D., Johnson, E., Griffiths, K., Kelly, E., & Henderson, G. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-33-10515.2003 · Cited by 87
Self-citationXiang, B., Yu, G., Guo, J. Q., Chen, L., Hu, W., Pei, G., & Ma, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006187200 · Cited by 85
Dhami, G. K., Dale, L. B., Anborgh, P. H., O'Connor‐Halligan, K. E., Sterne‐Marr, R., & Ferguson, S. S. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314090200 · Cited by 82
Pollok‐Kopp, B., Schwarze, K., Baradari, V. K., & Oppermann, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209844200 · Cited by 71
Salmeterol Stimulation Dissociates β2-Adrenergic Receptor Phosphorylation and Internalization
Moore, R. H., Millman, E. E., Godines, V., Hanania, N. A., Tran, T. M., Peng, H. C., Dickey, B. F., Knoll, B. J., & Clark, R. B. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0158oc · Cited by 70
Involvement of phospholipid signal transduction pathways in morphine tolerance in mice
Smith, F. L., Lohmann, A. B., & Dewey, W. L. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702771 · Cited by 68
Rapid Desensitization of the Serotonin2C Receptor System: Effector Pathway and Agonist Dependence
Stout, B. D., Clarke, W. P., & Berg, K. A. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.3.957 · Cited by 67
Lorenz, S., Frenzel, R., Paschke, R., Breitwieser, G. E., & Miedlich, S. U. (2007) · Endocrinology · doi:10.1210/en.2006-1035 · Cited by 66
Smith, F. L., Gabra, B. H., Smith, P. A., REDWOOD, M., & Dewey, W. L. (2006) · Pain · doi:10.1016/j.pain.2006.08.009 · Cited by 65
Vaughan, D. J., Millman, E. E., Godines, V., Friedman, J. E., Tran, T. M., Dai, W., Knoll, B. J., Clark, R. B., & Moore, R. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m500328200 · Cited by 63
Pula, G., Mundell, S. J., Roberts, P., & Kelly, E. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02387.x · Cited by 57
Self-citationMundell, S. J., Pula, G., McIlhinney, R. A. J., Roberts, P., & Kelly, E. (2004) · Biochemistry · doi:10.1021/bi0359022 · Cited by 52
Self-citationCastro, M., Dicker, F., Vilardaga, J., Krasel, C., Bernhardt, M., & Lohse, M. J. (2002) · Endocrinology · doi:10.1210/en.2002-220232 · Cited by 49
Hua, X.-Y., Moore, A., Malkmus, S. A., Murray, S., Dean, N. S., Yaksh, T. L., & Butler, M. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00157-4 · Cited by 48
Ligand-specific receptor states: Implications for opiate receptor signalling and regulation
Piñeyro, G., & Archer-Lahlou, É. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.05.026 · Cited by 46
Li, X., Huston, E., Lynch, M. J., et al. (2006) · Biochemical Journal · doi:10.1042/bj20051560 · Cited by 36
Semaphorin 4D activates the MAPK pathway downstream of plexin-B1
Aurandt, J., Li, W., & Guan, K. (2006) · Biochemical Journal · doi:10.1042/bj20051123 · Cited by 36
Jones, B. W., & Hinkle, P. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502918200 · Cited by 29
Mundell, S. J., Pula, G., More, J. C. A., Jane, D. E., Roberts, P., & Kelly, E. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1507 · Cited by 28
Self-citation
Cited by
Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance
Williams, J. T., Ingram, S. L., Henderson, G., Chavkin, C., von Zastrow, M., Schulz, S., Koch, T., Evans, C. J., & Christie, M. J. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005942 · Cited by 802
Self-citationKenakin, T., & Miller, L. J. (2010) · Pharmacological Reviews · doi:10.1124/pr.108.000992 · Cited by 573
MC4R-dependent suppression of appetite by bone-derived lipocalin 2
Mosialou, I., Shikhel, S., Liu, J.-M., Maurizi, A., Luo, N., He, Z., Huang, Y., Zong, H., Friedman, R. A., Barasch, J., et al. (2017) · Nature · doi:10.1038/nature21697 · Cited by 454
Lauffer, L. M., Iakoubov, R., & Brubaker, P. L. (2009) · Diabetes · doi:10.2337/db08-1237 · Cited by 399
Oxysterols direct B-cell migration through EBI2
Liu, C., Yang, X. V., Wu, J., Kuei, C., Mani, N. S., Zhang, L., Yu, J., Sutton, S. W., Qin, N., Banie, H., et al. (2011) · Nature · doi:10.1038/nature10226 · Cited by 387
Metadata
- Authors
- Kelly, E., Bailey, C. P., & Henderson, G.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2008-03
- Volume
- 153
- Issue
- S1
- Pages
- S379-88
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1699017532
- Cited by
- 388
- References
- 77
- FWCI
- 8.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.